Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

FDA clears Moderna, J&J Covid vaccine boosters, approves ‘mixing and matching’ vaccines

Chidinma AnyalewechibyChidinma Anyalewechi
1 year ago
in Coronavirus
FDA clears Moderna, J&J Covid vaccine boosters, approves ‘mixing and matching’ vaccines
Share on FacebookShare on TwitterShare on Linkedin

On Wednesday, the U.S regulator, Food and Drug Administration authorized booster shots of the Johnson & Johnson’s and Moderna’s Covid vaccines.

In the same vein, the U.S. regulator authorized the “mixing and matching” vaccines, which will allow Americans get a booster shot from a different drugmaker than the one that made their initial doses.

The FDA clearance came after the agency’s Vaccines and Related Biological Products Advisory Committee unanimously recommended additional shots of both vaccines last week.

What they are saying

“Today’s actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic,” acting FDA Commissioner Dr. Janet Woodcock said in a statement.

She further added, “As the pandemic continues to impact the country, science has shown that vaccination continues to be the safest and most effective way to prevent COVID-19, including the most serious consequences of the disease, such as hospitalization and death”.

What this means

The Moderna booster was recommended by the committee, for elderly people and vulnerable or at-risk adults six months after they must have completed their primary series of shots, bringing it in line with the distribution plan for Pfizer and BioNTech’s booster.

In addition, the U.S regulator also endorsed the J&J boosters for people 18 years and older who received the initial shot at least two months ago.

This ruling will now be handed off to the CDC and its vaccine advisory committee to issue a recommendation, and if the CDC Director, Dr. Rochelle Walensky signs off, additional shots for those vaccines will be distributed immediately to eligible people as another critical step in distributing extra doses to tens of millions of people.

The FDA and ultimately, the Center of Disease Control’s authorization would make booster doses available to the over 15 million people who have been inoculated with J&J’s shots and the more than 69 million people who have been fully immunized with Moderna’s vaccine.

Related

Tags: Johnson & Johnson’sModerna’s Covid vaccines.U.S. Food and Drug Administration

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Standard
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Amid a bearish market, Voltron Capital sees opportunities investing more in African startups
  • Buhari says naira redesign targets corrupt persons, terrorism financiers as CBN insists on January 31 deadline
  • INEC again extends deadline for collection of PVCs

Follow us on social media:

Recent News

Olumide Soyombo Founder Voltron Capital

Amid a bearish market, Voltron Capital sees opportunities investing more in African startups

January 29, 2023
Buhari says naira redesign targets corrupt persons, terrorism financiers as CBN insists on January 31 deadline

Buhari says naira redesign targets corrupt persons, terrorism financiers as CBN insists on January 31 deadline

January 28, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics